Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5608
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance ; day:14 ; month:8 ; year:2018 ; pages:1-7
Prostate cancer and prostatic diseases ; (14.8.2018), 1-7
- Urheber
-
Borque-Fernando, Ángel
- Beteiligte Personen und Organisationen
-
Rubio-Briones, José
Esteban, Luis M.
Dong, Yan
Calatrava, Ana
Gómez-Ferrer, Álvaro
Gómez-Gómez, Enrique
Gil Fabra, Jesús M.
Rodríguez-García, Nuria
López González, Pedro Á
García-Rodríguez, Jorge
Rodrigo-Aliaga, Miguel
Herrera-Imbroda, Bernardo
Soto-Villalba, Juan
Martínez-Breijo, Sara
Hernández-Cañas, Virginia
Soto-Poveda, Ana M.
Sánchez-Rodríguez, Carlos
Carrillo-George, Carlos
Hernández-Martínez, Yumaira E.
Okrongly, David
SpringerLink (Online service)
- DOI
-
10.1038/s41391-018-0074-5
- URN
-
urn:nbn:de:101:1-2018101200025733500418
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Borque-Fernando, Ángel
- Rubio-Briones, José
- Esteban, Luis M.
- Dong, Yan
- Calatrava, Ana
- Gómez-Ferrer, Álvaro
- Gómez-Gómez, Enrique
- Gil Fabra, Jesús M.
- Rodríguez-García, Nuria
- López González, Pedro Á
- García-Rodríguez, Jorge
- Rodrigo-Aliaga, Miguel
- Herrera-Imbroda, Bernardo
- Soto-Villalba, Juan
- Martínez-Breijo, Sara
- Hernández-Cañas, Virginia
- Soto-Poveda, Ana M.
- Sánchez-Rodríguez, Carlos
- Carrillo-George, Carlos
- Hernández-Martínez, Yumaira E.
- Okrongly, David
- SpringerLink (Online service)
Ähnliche Objekte (12)
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Biparametric MRI in prostate cancer during active surveillance: is it safe?
Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis
The utility of prostate MRI within active surveillance: description of the evidence
Risk of progression following a negative biopsy in prostate cancer active surveillance
Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies
Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Biparametric MRI in prostate cancer during active surveillance: is it safe?
Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis
The utility of prostate MRI within active surveillance: description of the evidence
Risk of progression following a negative biopsy in prostate cancer active surveillance
Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies
Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Biparametric MRI in prostate cancer during active surveillance: is it safe?
Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis
The utility of prostate MRI within active surveillance: description of the evidence
Risk of progression following a negative biopsy in prostate cancer active surveillance
Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies